Reportstack has announced a new market research publication on Global Therapeutic Vaccines Market 2014-2018. A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period. The Global Therapeutic Vaccines market is expected to grow at a CAGR of 62.81 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.
The Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Agenus Inc.
Bavarian Nordic A/S.
Dendreon Corp.
GlaxoSmithKline plc
Novartis International AG
Other Prominent Vendors
AFFiRiS AG.
Argos Therapeutics Inc.
Celldex Therapeutics Inc.
CEL-SCI Corp.
Cytos Biotechnology AG
GlobeImmune Inc.
NewLink Genetics Corp.
NovaRx Corp.
Oncothyreon Inc.
TVAX Biomedical Inc.
TapImmune Inc.
Vical Inc.
Vaccinogen Inc.
Market Driver
Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
Ongoing Development of a Large Number of Therapeutic Vaccines
Market Challenge
Stringent Regulations
Adverse Side Effects of Therapeutic Vaccines
Market Trend
Improved Understanding of Immunology and Immunotherapy
Increase in Mergers and Acquisitions
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.
The Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Agenus Inc.
Bavarian Nordic A/S.
Dendreon Corp.
GlaxoSmithKline plc
Novartis International AG
Other Prominent Vendors
AFFiRiS AG.
Argos Therapeutics Inc.
Celldex Therapeutics Inc.
CEL-SCI Corp.
Cytos Biotechnology AG
GlobeImmune Inc.
NewLink Genetics Corp.
NovaRx Corp.
Oncothyreon Inc.
TVAX Biomedical Inc.
TapImmune Inc.
Vical Inc.
Vaccinogen Inc.
Market Driver
Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
Ongoing Development of a Large Number of Therapeutic Vaccines
Market Challenge
Stringent Regulations
Adverse Side Effects of Therapeutic Vaccines
Market Trend
Improved Understanding of Immunology and Immunotherapy
Increase in Mergers and Acquisitions
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
To view the table of contents and know more details please visit Global Therapeutic Vaccines Market 2014-2018 report.
No comments:
Post a Comment